Intravenous bisphosphonate-related osteonecrosis of the jaw: Long-term follow-up of 109 patients

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Volumn 115, Issue 2, 2013, Pages 192-200

  Watters, Amber L ^a,b   Hansen, Heidi J ^a,c   Williams, Tijaana ^a   Chou, Joanne F ^b   Riedel, Elyn ^b   Halpern, Jerry ^a   Tunick, Steven ^a   Bohle, George ^a   Huryn, Joseph M ^a   Estilo, Cherry L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; IMIDAZOLE DERIVATIVE; PAMIDRONIC ACID; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; COMORBIDITY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; JAW OSTEONECROSIS; MALE; MIDDLE AGED; RISK FACTOR; SMOKING; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DIABETES MELLITUS; DIPHOSPHONATES; DISEASE PROGRESSION; DMF INDEX; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; NEW YORK CITY; RISK FACTORS; SMOKING;

EID: 84872294856     PISSN: 22124403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oooo.2012.05.017     Document Type: Article

References (23)

1. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 2003 1115 1117
2. S.L. Ruggiero, B. Mehrotra, T.J. Rosenberg, S.L. Engroff Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases J Oral Maxillofac Surg 62 2004 527 534
3. M.R. Allen, D.B. Burr The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data J Oral Maxillofac Surg 67 2009 61 70
4. S.L. Ruggiero, T.B. Dodson, L.A. Assael, R. Landesberg, R.E. Marx, B. Mehrotra American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update J Oral Maxillofac Surg 67 2009 2 12
5. K. Vahtsevanos, A. Kyrgidis, E. Verrou, E. Katodritou, S. Triaridis, C.G. Andreadis Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw J Clin Oncol 27 2009 5356 5362
6. O. Nicolatou-Galitis, E. Papadopoulou, T. Sarri, P. Boziari, A. Karayianni, M.C. Kyrtsonis Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112 2011 195 202
7. F. Moretti, G.A. Pelliccioni, L. Montebugnoli, C. Marchetti A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphosphonate-associated osteonecrosis of the jaws Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112 2011 777 782
8. M.J. Favus Diabetes and the risk of osteonecrosis of the jaw J Clin Endocrinol Metab 92 2007 817 818
9. S.G. Grossi, J.J. Zambon, A.W. Ho, G. Koch, R.G. Dunford, E.E. Machtei Assessment of risk for periodontal-disease risk indicators for attachment loss J Periodontol 65 1994 260 267
10. L.M. Hess, J.M. Jeter, M. Benham-Hutchins, D.S. Alberts Factors associated with osteonecrosis of the jaw among bisphosphonate users Am J Med 121 2008 475 483.e3
11. T.S. Lazarovici, R. Yahalom, S. Taicher, S. Elad, I. Hardan, N. Yarom Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients J Oral Maxillofac Surg 67 2009 850 855
12. M. Khamaisi, E. Regev, N. Yarom, B. Avni, E. Leitersdorf, I. Raz, S. Elad Possible association between diabetes and bisphosphonate-related jaw osteonecrosis J Clin Endocrinol Metab 92 2007 1172 1175
13. S. Hoefert, I. Schmitz, A. Tannapfel, H. Eufinger Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and nonsymptomatic osteonecrosis of the jaw based on scanning electron microscopy findings Clin Oral Investig 14 2010 271 284
14. A.M. Vandone, M. Donadio, M. Mozzati, M. Ardine, M.A. Polimeni, S. Beatrice Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience Ann Oncol 23 2012 193 200
15. K.E. Fleisher, G. Welch, S. Kottal, R.G. Craig, D. Saxena, R.S. Glickman Predicting risk for bisphosphonate-related osteonecrosis of the jaws: Ctx versus radiographic markers Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110 2010 509 516
16. C.L. Estilo, C.H. Van Poznak, T. Wiliams, G.C. Bohle, P.T. Lwin, Q. Zhou Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy Oncologist 13 2008 911 920
17. I.R. Reid, M.J. Bolland, A.B. Grey Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 41 2007 318 320
18. S.C. Gelskey Cigarette smoking and periodontitis: methodology to assess the strength of evidence in support of a causal association Community Dent Oral Epidemiol 27 1999 16 24
19. J.W.P. Kuiper, C. Forster, C. Sun, S. Peel, M. Glogauer Zoledronate and pamidronate depress neutrophil functions and survival in mice Br J Pharmacol 165 2012 532 539
20. J.S. Reuben, L. Dinh, J. Lee, J. Stateson, H. Kamara, L. Xiang, L.A. Opperman Bisphosphonates inhibit phosphorylation of signal transducer and activator of transcription 3 and expression of suppressor of cytokine signaling 3: implications for their effects on innate immune function and osteoclastogenesis Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111 2011 196 204
21. G. Ferretti, A. Fabi, P. Carlini, P. Papaldo, P.C. Fei, S. di Cosimo Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients Oncology 69 2005 35 43
22. C. Christodoulou, A. Pervena, G. Klouvas, E. Galani, M.E. Falagas, G. Tsakalos Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone Oncology 76 2009 209 211
23. K. Zervas, E. Verrou, Z. Teleioudis, K. Vahtsevanos, A. Banti, D. Mihou Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: A single-centre experience in 303 patients Br J Haematol 134 2006 620 623